1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. KYMERA THERAPEUTICS INC

Kymera Therapeutics Inc

XNAS: KYMR

Weak Stock
Download real time

25.18 0.16 (0.64%)

52.73% Fall from 52W High

120.0K XNAS Volume

XNAS 17 Apr, 2025 11:35 AM (EDT)

Watchlist

Portfolio

Share
7S
17W
1O
2T
1,635.3

Market Cap

High in industry
-7.3

PE TTM

Negative PE TTM
0.1

PEG TTM

PEG TTM is less than 1
2

Price to Book

Below industry Median
0.4

Beta 1Year

Very Low volatility

Kymera Therapeutics Inc - KYMR - stock price prediction, stock price target, analyst ratings from 19 analysts

Kymera Therapeutics Inc has a share price target of US$ 58, revenue growth forecast of 27.7%, and profit growth estimate of -32.6% for FY25, based on top 19 analyst calls.

Forecaster Screeners